New England Biolabs Expands NGS Portfolio with Long-Read and Methylation Advances
Event summary
- New England Biolabs (NEB) will present updates on NGS sample preparation at the 2026 AGBT Meeting (Feb 23-26).
- NEB launching NEBNext UltraShear® Long Read for DNA fragmentation (2-30 kb) at the event.
- Company introducing Monarch® Mag Cell-free DNA Extraction Kit for scalable cfDNA isolation.
- Presentations include cross-platform methylome sequencing and small RNA library prep advancements.
The big picture
NEB's product updates at AGBT 2026 reflect the growing demand for advanced NGS sample preparation solutions. The company's focus on long-read sequencing and methylation analysis aligns with industry trends toward more comprehensive genomic profiling. NEB's private status allows for long-term R&D investment, positioning it as a key player in the competitive biotech tools market.
What we're watching
- Technology Adoption
- How NEB's UltraShear Long Read technology will impact long-read sequencing efficiency.
- Market Differentiation
- Whether NEB can sustain competitive advantage with its enzymatic methyl sequencing advancements.
- Clinical Applications
- The pace at which NEB's cfDNA solutions gain traction in clinical diagnostics.
Related topics